Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IMDX

Insight Molecular Diagnostics Inc.

CIK 0001642380 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$4.34
↑ 0.04 (0.93%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$142.02M
P/E Ratio
-2.88
EPS
-1.65
Dividend Yield
Not covered
52W Position
33%
Beta
2.47

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-6.67
P/S
85.04
EV/Revenue
74.41
ROE
231.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 33%
$2.33$8.51

Latest Financials

2025-12-31 FY
Revenue
$4.05M
Net Income
-$50.22M
Total Assets
$25.76M
Free Cash Flow
-$25.37M

Recent news